1329132 is referenced by 2 patents.

ABSTRACT OF THE DISCLOSURE The monoamine oxidase inhibitor drug L-deprenyl (phenylisopropyl methyl propynyl amine) may be safely andconveniently used for the treatment of mental depression, Parkinson's or Alzheimer's Disease in a formulation appliedto the skin of the patient. In this way the danger of sidereation due to the consumption of foods containing tyramine (the cheese effect) is minimized, Unlike other monoamineoxidase drugs, L-deprenyl does not cause skin irritation whenused in this way.

Title
Methode dadministration du deprenyl, permettant de reduire au minimum les effets secondaires du produit
Method for administering the drug deprenyl so as to minimize the danger of side effects
Application Number
585506
Publication Number
1329132
Application Date
December 9, 1988
Publication Date
May 3, 1994
Inventor
Buyske Donald A
Agent
SHAPIRO COHEN
Assignee
Somerset Pharmaceuticals
IPC
A61K 09/70
A61K 31/135
View Original Source